Literature DB >> 3400

Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.

R A Van Dyke, A J Gandolf.   

Abstract

Halothane has been found to undergo a reductive defluorination. This reaction requires an active cytochrome P-450 system and NADPH, and is inducible by phenobarbital and polychlorinated biphenyls but not by methylcholanthrene. The fluoride release occurs only under low O2 tension, while high O2 tension results in the oxidation of halothane to trifluoroacetic acid, inorganic bromide, and chloride. The release of the inorganic fluoride is linear up to 60 min. Because the conditions required for fluoride release and the binding of a halothane metabolite to microsomal phospholipids are similar, the defluorinated halothane molecule is assumed to be involved with this binding. However, based on the amount of fluoride released, the defluorinated halothane metabolite represents only approximately 60% of the total amount of halothane metabolite bound, which suggests that more than one metabolite may be involved in the binding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3400

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

Review 1.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Saturable binding of halothane to rat brain synaptosomes.

Authors:  E A el-Maghrabi; R G Eckenhoff; H Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 3.  Halothane hepatitis: what's new?

Authors:  M J Cousins
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

Review 4.  Reductive Cytochrome P450 Reactions and Their Potential Role in Bioremediation.

Authors:  James B Y H Behrendorff
Journal:  Front Microbiol       Date:  2021-04-15       Impact factor: 5.640

Review 5.  Toxicology of chlorofluorocarbon replacements.

Authors:  W Dekant
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

6.  Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane.

Authors:  A J Garro; R A Phillips
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

Review 7.  Absorption, biotransformation, and storage of halothane.

Authors:  D A Holaday
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

8.  Effect of enzyme induction on nephrotoxicity of halothane-related compounds.

Authors:  B A Hitt; R I Mazze
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

9.  Dechloriation mechanisms of chlorinated olefins.

Authors:  R A Van Dyke
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.